Valeroyl Salicylate
CAS No. 64206-54-8
Valeroyl Salicylate( 2-Valeryloxybenzoic acid )
Catalog No. M27485 CAS No. 64206-54-8
Valeroyl Salicylate is a non-steroidal anti-inflammatory agent and can lead to extension of lifespan, delays age-dependent decline of locomotor activity, and increases stress resistance.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 49 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameValeroyl Salicylate
-
NoteResearch use only, not for human use.
-
Brief DescriptionValeroyl Salicylate is a non-steroidal anti-inflammatory agent and can lead to extension of lifespan, delays age-dependent decline of locomotor activity, and increases stress resistance.
-
DescriptionValeroyl Salicylate is a non-steroidal anti-inflammatory agent and can lead to extension of lifespan, delays age-dependent decline of locomotor activity, and increases stress resistance.
-
In Vitro——
-
In VivoAnimal Model:25-30g, Swiss male mice (arachidonic acid induces Ear oedema)Dosage:1.5, 4.5, 15, 45 μg per earAdministration:Result:Showed the anti-inflammatory effect of topical administration and resulted in significant inhibition of the ear oedema of28, 36, 40, and 58% at 1.5, 4.5, 15, 45 μg per ear.Animal Model:25-30g, Swiss male mice (Carrageenan-induced paw oedema) Dosage:3, 10, 30 mg/kg Administration:I.p.Result:Promoted a significant inhibition of 43.3, 53.3 and 66.6% at 3, 10, 30 mg/kg, respectively.
-
Synonyms2-Valeryloxybenzoic acid
-
PathwayOthers
-
TargetOther Targets
-
Recptoramyloid-β
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number64206-54-8
-
Formula Weight222.24
-
Molecular FormulaC12H14O4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCCCCC(Oc(cccc1)c1C(O)=O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Philippe Verwaerde. Alzprotect Strengthens Its Intellectual Property Portfolio for Its First-in-Class Clinical Stage Drug Ezeprogind
molnova catalog
related products
-
Cathepsin G (77 - 83...
Cathepsin G (77 - 83)
-
SCPA
SCPA
-
Neurotensin (Frog)
Neurotensin (Frog)
Cart
sales@molnova.com